Article for Self-Administered Drugs and Biologicals Excluded from Coverage - Medical Policy Article (A47529)

Contractor Information

Contractor Name 

National Government Services, Inc.  

Contractor Number 

00454 

Contractor Type 

FI 

Article Information

Article ID Number 

A47529 

Article Type 

SAD Exclusion Article

Key Article 

Yes

Article Title 

Self-Administered Drugs and Biologicals Excluded from Coverage - Medical Policy Article 

AMA CPT / ADA CDT Copyright Statement 

CPT codes, descriptions and other data only are copyright 2007 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association.© 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.

 

Primary Geographic Jurisdiction 

American Samoa
Guam
Hawaii
Nevada
Northern Mariana Islands
 

Secondary Geographic Jurisdiction 

American Samoa
Guam
Hawaii
Nevada
Northern Mariana Islands
 

Original Article Effective Date 

07/01/2008

Article Revision Effective Date 

07/01/2008

 

Article Text 

The table below lists drugs that are not covered by Medicare, the effective date of non-coverage, and the rationale. (Please see "Process for Determining Self-Administered Drug Exclusions – Medical Policy Article"). The column, "Brand Names," provides one or more examples but not all. Information about drugs not separately reimbursed or not covered for reasons other than "usually self-administered," is found in other carrier and fiscal intermediary publications and sites.

In the interest of consistent Medicare coverage, the National Government Services fiscal intermediary will follow the coverage decision for self-administered drugs as determined by the carrier in each respective state. HCPCS codes for the same drugs that apply only to providers that bill the fiscal intermediary (e.g., HCPCS codes used for drugs billable under the Outpatient Prospective Payment System [OPPS]) are included when applicable.

 

Coverage Topic 

Outpatient Hospital Services
Prescription Drugs 

 

Coding Information

No Coding Information has been entered in this section of the article.

Coding Table Information

CPT/HCPCS Codes - Table Format 

Code

Descriptor Generic Name

Descriptor Brand Name

Exclusion Effective Date

Exclusion End Date

Comments

J0135

INJECTION, ADALIMUMAB, 20 MG

Injection, Adalimumab, 20 mg, Humira, Injection, alprostadil

11/01/2003

N/A

 

J0270

INJECTION, ALPROSTADIL, 1.25 MCG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Alprostadil, Caverjet, Edex®, Prostin VR®, 1.25 mcg

01/15/2003

N/A

 

J0275

ALPROSTADIL URETHRAL SUPPOSITORY (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Alprostadil urethral suppository (Muse®), variable

01/15/2003

N/A

 

J0630

INJECTION, CALCITONIN SALMON, UP TO 400 UNITS

Injection Calcitonin-salmon up to 400 unites, Calcimar®, Miacalcin®, up to 400 units

01/15/2003

N/A

 

J1438

INJECTION, ETANERCEPT, 25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Injection etanercept (Enbrel®), 25 mg

01/15/2003

N/A

 

J1562

INJECTION, IMMUNE GLOBULIN (VIVAGLOBIN), 100 MG

Injection, immune globulin, subcutaneous, 100mg (Vivaglobulin®)

04/15/2007

N/A

 

J1595

INJECTION, GLATIRAMER ACETATE, 20 MG

Injection, glatiramer acetate (Copaxone®), 20 mg

05/01/2004

N/A

 

J1650

INJECTION, ENOXAPARIN SODIUM, 10 MG

Injection, enoxaparin sodium, 10 mg (Lovenox®)

11/01/2006

N/A

 

J1652

INJECTION, FONDAPARINUX SODIUM, 0.5 MG

Injection, Fondaparinux sodium, 0.5 mg (Arixtra®)

04/15/2006

N/A

 

J1675

INJECTION, HISTRELIN ACETATE, 10 MICROGRAMS

Injection, histrelin acetate, 10 micrograms

08/15/2006

N/A

 

J1815

INJECTION, INSULIN, PER 5 UNITS

Injection, insulin, per 5 units (Humalog® Humulin®, Iletin®, Insulin Lispro®, Novo Nordisk®, NPH®, Pork insulin, Regular insulin, Ultralente®, Velosulin®, Humulin R®, Iletin II Regular Pork®, Insulin Purified Pork, Relion®, Lente Iletin I®, Novolin R®, Humulin R U-500®)

11/01/2003

N/A

 

J1817

INSULIN FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS

Insulin for administration through DME (i.e. insulin pump) per 50 units (Humalog®, Humulin®, Vesolin BR®, Iletin II NPH Pork, Lantus®, Lispro-PFC®, Novolin®, Novolog®, Novolog Flexpen®, Novolog Mix, Relion ®,Novolin®)

01/15/2003

N/A

 

J1830

INJECTION INTERFERON BETA-1B, 0.25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Interferon beta-1b (Betaseron®), 0.25 mg

01/15/2003

N/A

 

J2170

INJECTION, MECASERMIN, 1 MG

Injection, mecasermin (Increlex®, Iplex®), 1 mg

04/15/2007

N/A

 

J2354

INJECTION, OCTREOTIDE, NON-DEPOT FORM FOR SUBCUTANEOUS OR INTRAVENOUS INJECTION, 25 MCG

Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg (Sandostatin®)

10/15/2005

N/A

 

J2440

INJECTION, PAPAVERINE HCL, UP TO 60 MG

Injection, papaverine HCI, up to 60 mg

11/01/2003

N/A

 

J2940

INJECTION, SOMATREM, 1 MG

Injection, somatrem (Protropin®), 1 mg

01/15/2003

N/A

 

J2941

INJECTION, SOMATROPIN, 1 MG

Injection somatropin 1 mg (Humatrope®, Genotropin®, Nutropin®), Biotropin®, Genotropin®, Genotropin Miniquick®, Norditropin®, Nutropin AQ®, Saizen®, Saizen Somatropin®, RDNA Origin®, Serostim®, B, C
Serostim RDNA Origin®, Zorbtive®)

01/15/2003

N/A

 

J3030

INJECTION, SUMATRIPTAN SUCCINATE, 6 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED)

Injection, sumatriptan succinate (Imitrex®), 6 mg

01/15/2003

N/A

 

J3110

INJECTION, TERIPARATIDE, 10 MCG

Injection, teriparatide (Forteo®), 10 mcg

11/01/2003

N/A

 

J3140

INJECTION, TESTOSTERONE SUSPENSION, UP TO 50 MG

Injection, testosterone suspension, up to 50 mg

10/15/2005

N/A

 

J3150

INJECTION, TESTOSTERONE PROPIONATE, UP TO 100 MG

Injection, testosterone propionate, up to 100 mg

10/15/2005

N/A

 

J3355

INJECTION, UROFOLLITROPIN, 75 IU

Injection, Urofollitropin (Bravelle®, Fertinex®, Follistim®, Gonal-F®), 75 IU

04/15/2007

N/A

 

J3490

UNCLASSIFIED DRUGS

Exanatide (Byetta®), variable

04/15/2006

N/A

 

J1324

INJECTION, ENFUVIRTIDE, 1 MG

Enfuvirtide (Fuzeon®), 1 mg

05/01/2004

N/A

 

J3490

UNCLASSIFIED DRUGS

Pramlintide acetate (Symlin®)

04/15/2006

N/A

 

J3590

UNCLASSIFIED BIOLOGICS

Anakinra (Kineret®), variable

10/15/2005

N/A

 

J3590

UNCLASSIFIED BIOLOGICS

Efalizumab (Raptiva®), variable

05/01/2004

N/A

 

J3590

UNCLASSIFIED BIOLOGICS

Peginterferon, alfa-2a (Pegasys®), variable

05/01/2005

N/A

 

J3590

UNCLASSIFIED BIOLOGICS

Peginterferon, alfa-2b (Peg-Intron®), variable

11/01/2003

N/A

 

J3590

UNCLASSIFIED BIOLOGICS

Pegvisomant (Somavert®), variable

05/01/2004

N/A

 

J9212

INJECTION, INTERFERON ALFACON-1, RECOMBINANT, 1 MCG

Injection, interferon alfacon-1 (Infergen®), recombinant, 1 mcg

11/01/2003

N/A

 

J9213

INTERFERON, ALFA-2A, RECOMBINANT, 3 MILLION UNITS

Interferon, alfa-2A (Roferon-A®), recombinant, 3 million units

11/01/2003

N/A

 

J9216

INTERFERON, GAMMA 1-B, 3 MILLION UNITS

Interferon gamma-1b (Actimmune®), 3 million units

01/15/2003

N/A

 

J9218

LEUPROLIDE ACETATE, PER 1 MG

Leuprolide acetate, (Lupron®, Eligard®), 1 mg

01/15/2003

N/A

 

Q0515

INJECTION, SERMORELIN ACETATE, 1 MICROGRAM

Injection, sermorelin acetate (Geref®), 1 microgram

04/15/2007

N/A

 

Other Information

Other Comments 

Not applicable

Revision History Explanation 

Article published June 2008: This article replaces - A2372 - Self-Administered Drug Exclusion - Medical Policy Article.

 

Related Documents 

 

Article(s)
A47521 - Process for Determining Self-Administered Drug Exclusions – Medical Policy Article